Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of imatinib + 5-FU/leucovorin in advanced gallbladder and bile duct carcinoma
2006-003451-20Phase 2Completed
- Sponsor
- Technische Universität Dresden
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in gallbladder cancer and cholangiocarcinoma (CCA), sponsored by Technische Universität Dresden. Primary endpoint: Disease control rate. Started Dec 2006; status: completed.
02
Drugs
03
Conditions
gallbladder cancercholangiocarcinoma (CCA)
Beyond the preview
Go deeper on 2006-003451-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003451-20.